-
1
-
-
0027737994
-
Lack of usefulness of prolonged bleeding time in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody
-
M.M. Bernardi, et al. (1993) Lack of usefulness of prolonged bleeding time in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. Am J Cardiol 72 1121-1125.
-
(1993)
Am J Cardiol
, vol.72
, pp. 1121-1125
-
-
Bernardi, M.M.1
-
2
-
-
0025166288
-
A critical reappraisal of the bleeding time
-
R. Rogers and J. Levin (1990) A critical reappraisal of the bleeding time. Sem Thromb Hemost 16 1-20.
-
(1990)
Sem Thromb Hemost
, vol.16
, pp. 1-20
-
-
Rogers, R.1
Levin, J.2
-
3
-
-
0018857958
-
Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: Defective platelet-fibrinogen interaction in thrombasthenia
-
B.S. Coller (1980) Interaction of normal, thrombasthenic, and Bernard-Soulier platelets with immobilized fibrinogen: Defective platelet-fibrinogen interaction in thrombasthenia. Blood 55 169-178.
-
(1980)
Blood
, vol.55
, pp. 169-178
-
-
Coller, B.S.1
-
4
-
-
0025821449
-
Monoclonal antibodies to platelet GPIIb/IIIa as antithrombotic agents
-
B.S. Coller, et al. (1991) Monoclonal antibodies to platelet GPIIb/IIIa as antithrombotic agents. Ann NY Acad Sci 614 193-213.
-
(1991)
Ann NY Acad Sci
, vol.614
, pp. 193-213
-
-
Coller, B.S.1
-
5
-
-
0031058513
-
Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade
-
B.S. Coller, D. Lang and L.E. Scudder (1997) Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. Circulation 95 860-867.
-
(1997)
Circulation
, vol.95
, pp. 860-867
-
-
Coller, B.S.1
Lang, D.2
Scudder, L.E.3
-
6
-
-
0033537494
-
Rapid platelet-function assay: An automated and quantitative cartridge-based method
-
J.W. Smith, et al. (1999) Rapid platelet-function assay: An automated and quantitative cartridge-based method. Circulation 99 620-625.
-
(1999)
Circulation
, vol.99
, pp. 620-625
-
-
Smith, J.W.1
-
7
-
-
0347359012
-
2+responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced prostaglandin E1
-
S.C. Fox, M.W. Behan and S. Heptinstall (2004) Inhibition of ADP-induced intracellular Ca 2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced prostaglandin E1. Cell Calcium 35 39-46.
-
(2004)
Cell Calcium
, vol.35
, pp. 39-46
-
-
Fox, S.C.1
Behan, M.W.2
Heptinstall, S.3
-
8
-
-
0036242793
-
The Ultegra rapid plateletfunction assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abcix
-
G.L. Wheeler, et al. (2002) The Ultegra rapid plateletfunction assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abcix. Am Heart J 143 602-611.
-
(2002)
Am Heart J
, vol.143
, pp. 602-611
-
-
Wheeler, G.L.1
-
9
-
-
0035070161
-
A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary interventio receiving abciximab, eptifibatide, or tirofi — ban
-
D.I. Simon, et al. (2001) A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary interventio receiving abciximab, eptifibatide, or tirofi — ban. Cathet Cardiovasc Intervent 52 425-432.
-
(2001)
Cathet Cardiovasc Intervent
, vol.52
, pp. 425-432
-
-
Simon, D.I.1
-
10
-
-
0000742817
-
The Accumetrics Rapid Platelet Function Analyzer (RPFA) to monitor platelet aggregation during oral administration of a GPIIb/IIIa antagonist (abstract)
-
P. Theroux, et al. (1999) The Accumetrics Rapid Platelet Function Analyzer (RPFA) to monitor platelet aggregation during oral administration of a GPIIb/IIIa antagonist (abstract). J Am Coll Cardiol 33(Suppl A), 330A.
-
(1999)
J Am Coll Cardiol
, vol.33
, pp. 330A
-
-
Theroux, P.1
-
11
-
-
2942555599
-
Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer
-
A. Malinin, et al. (2004) Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer. Blood Coagul Fibrinolysis 15 295-301.
-
(2004)
Blood Coagul Fibrinolysis
, vol.15
, pp. 295-301
-
-
Malinin, A.1
-
12
-
-
18244392669
-
Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregomet
-
P. Harrison, et al. (2005) Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregomet. Stroke 36 1001-1005.
-
(2005)
Stroke
, vol.36
, pp. 1001-1005
-
-
Harrison, P.1
-
13
-
-
27744516843
-
Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel. Results of the ISAR-CHOICE (Intracoronary Stentin Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial
-
N. von Beckerath, et al. (2005) Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel. Results of the ISAR-CHOICE (Intracoronary Stentin Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation 112 2946-2950.
-
(2005)
Circulation
, vol.112
, pp. 2946-2950
-
-
von Beckerath, N.1
-
14
-
-
84884747481
-
Correlation between platelet response units measured with a point-of-care test and ADPinduced platelet aggregation assessed with conventional optical aggregom
-
(Abstract Supplement)
-
N. von Beckerath, et al. (2005) Correlation between platelet response units measured with a point-of-care test and ADPinduced platelet aggregation assessed with conventional optical aggregom. Eur Heart J 26 479. (Abstract Supplement)
-
(2005)
Eur Heart J
, vol.26
, pp. 479
-
-
von Beckerath, N.1
-
15
-
-
15944383861
-
Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases
-
B. Aleil, et al. (2005) Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 3 85-92.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 85-92
-
-
Aleil, B.1
-
16
-
-
0024848055
-
Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, p aggregation, and blockade of GPIIb/IIIa receptors
-
B.S. Coller, et al. (1989) Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, p aggregation, and blockade of GPIIb/IIIa receptors. Circulation 80 1766-1774.
-
(1989)
Circulation
, vol.80
, pp. 1766-1774
-
-
Coller, B.S.1
-
17
-
-
0023838863
-
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet antibody in a dog model
-
H.K. Gold, et al. (1988) Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet antibody in a dog model. Circulation 77 670-677.
-
(1988)
Circulation
, vol.77
, pp. 670-677
-
-
Gold, H.K.1
-
18
-
-
0035853027
-
Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event following percutaneous coronary intervention. Results of (AU-Assessing Ultegra) multicenter study
-
S. Steinhubl, et al. (2001) Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event following percutaneous coronary intervention. Results of (AU-Assessing Ultegra) multicenter study. Circulation 103 1403-1409.
-
(2001)
Circulation
, vol.103
, pp. 1403-1409
-
-
Steinhubl, S.1
-
19
-
-
0036711197
-
Effectiveness of tirofi ban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)
-
A.S. Kini, et al. (2002) Effectiveness of tirofi ban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study). Am J Cardiol 90 526-529.
-
(2002)
Am J Cardiol
, vol.90
, pp. 526-529
-
-
Kini, A.S.1
-
20
-
-
10744230699
-
Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA
-
J.C. Wang, et al. (2003) Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA. Am J Cardiol 92 1492-1494.
-
(2003)
Am J Cardiol
, vol.92
, pp. 1492-1494
-
-
Wang, J.C.1
-
21
-
-
1542708471
-
Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
-
W.H. Chen, et al. (2004) Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43 1122-1126.
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1122-1126
-
-
Chen, W.H.1
-
22
-
-
24944525789
-
Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary intervention
-
W.H. Chen, et al. (2005) Relation of aspirin resistance to coronary flow reserve in patients undergoing elective percutaneous coronary intervention. Am J Cardiol 96 760-763.
-
(2005)
Am J Cardiol
, vol.96
, pp. 760-763
-
-
Chen, W.H.1
-
23
-
-
21244446907
-
Low-dose aspirin increases aspirin resistance in patients with coronary artery disease
-
P. Lee, et al. (2005) Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 118 723-727.
-
(2005)
Am J Med
, vol.118
, pp. 723-727
-
-
Lee, P.1
-
25
-
-
24944474901
-
Aspirin resistance: Position paper of the Working Group on Aspirin Resistance
-
A.D. Michelson, et al. (2005) Aspirin resistance: Position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 3 1309-1311.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1309-1311
-
-
Michelson, A.D.1
-
26
-
-
8344221349
-
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
-
S. Matetzky, et al. (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109 3171-3175.
-
(2004)
Circulation
, vol.109
, pp. 3171-3175
-
-
Matetzky, S.1
-
27
-
-
0038291914
-
Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement
-
I. Muller, et al. (2003) Prevalence of clopidogrel nonresponders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 89 783-787.
-
(2003)
Thromb Haemost
, vol.89
, pp. 783-787
-
-
Muller, I.1
|